• Published guidelines for follow up after R0 resection of GEP-NETS are complex.
-Closer surveillance in the first 3 years is emphasized, as per other GI malignancies. -Knowledge of, and compliance with guidelines may vary widely.
• NETs are heterogeneous, and the pattern and timescale of recurrence is poorly documented.
-Follow up schedules impact on patient experience and health resource utilization. Practical and tailored follow up would be more appropriate than broad guidelines which may overinvestigate.
• As part of a larger project to define optimal follow up for fully resected NETs, we performed a detailed survey of real world practices amongst CommNETs and NANETs members to assess current practice.
Aim
To examine real world follow up practices for patients with resected GEP-NETs.
Methods
• A detailed electronic survey was developed and distributed during a 2-week period to the member database of the CommNETs Collaboration and NANETs.
-Australia, New Zealand, Canada, United States -NET physicians, nurses and allied health professionals
• Questions addressed the following areas: -Demographics of respondent -Knowledge and use of current guidelines -Follow up practices (frequency and modality) according to various prognostic factors
• Descriptive statistics were reported.
-Stratified by country, patient volume and specialty.
-For stratified analyses, follow up patient care volume was categorized as "low" (0-10 patients per year), "medium" (11-50) and "high" (>50).
Prognostic factors influencing follow up patterns:
• Grade and Ki-67/mitotic count were considered the most important prognostic factors when deciding follow up protocols for individual patients (Table 2 ).
• Follow up in the first 2 years was most commonly every 6 months (62%); in years 3-5 every 12 months (59%) and > 5 years, 12 months (41%).
-In general, patients were discharged from NET-specific follow up after 5 years (28%), 6-10 years (26%) or > 10 years (23%) of follow up. No change (59%), increased follow up (21%)
• The commonest investigations ordered were CT scans (66%) and CgA (86%).
-Follow up investigations did not differ significantly according to country, patient volume or specialty of respondent.
• Follow up patterns vary widely amongst different specialists and countries but appear uninfluenced by patient volume • Current guidelines do not appear to be widely adopted • Various prognostic factors affect follow up frequency and investigations, particularly grade and Ki-67
Conclusions
• This large international survey yields detailed information about variation in current follow up practices and raises questions about the applicability of current guidelines.
• More data regarding patterns and timelines of NET recurrences is needed. Detailed examination of recurrences in a large population database is currently underway as part of the CommNETS follow up project.
• This survey information was used in combination with the aforementioned data as the foundation of a CommNETS/NANETS Expert Consensus meeting on Optimal Follow up of fully resected GI-NETs held in December 2016 which produced scenario-based, practical guidelines.
Demographics:
• 163 respondents contributed to the survey -Australia (59), New Zealand (25), Canada (46), US (33) -50% Medical Oncology, 23% Surgery, 13% Nuclear Medicine, 14% Others -NET patient volumes varied widely (Table 1) -Interpretation of various terminology eg 'complete resection' was highlighted as a potentially confounding issue when discussing optimal follow up Familiarisation with NET follow up guidelines:
• 38% were "very familiar" with NCCN NET guidelines, 33% with ENETs, and 17% with ESMO (Fig 1) -However, only 15%, 27% and 10% respectively found them "very useful" (Fig 2) -63% reported that their institution did not have guidelines regarding NET follow up; there were various reasons for not developing or following guidelines (Fig 3) Lesley.Moody@cancercare.on.ca 
